Cardiac Biomarkers Market Value Expected to Reach US$ 11.6 Billion By 2018-2024

by Rahul Rastogi Market Research Analyst

According to the latest report by IMARC Group titled, “Cardiac Biomarkers Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2024”, the market reached a value of US$ 6.9 Billion 2018. Looking forward, the global cardiac biomarkers market size is expected to reach a value of US$ 11.6 Billion by 2024, exhibiting a CAGR of around 9% during 2019-2024.

Cardiac biomarkers help as risk stratification for various cardiovascular diseases including myocardial infraction, congestive heart failure, and acute coronary syndrome.

The major reason associated with this sharp rise in the demand for cardiac biomarkers is the increasing number of patients suffering from acute coronary syndrome across the globe. Other factors include continual technological advancements in the development of cardiovascular biomarkers, introduction of new product launches by the companies, rise in demand for point-of-care cardiac testing kits and high-specificity and -sensitivity of these biomarkers in detecting cardiovascular diseases, especially acute myocardial infarction. Apart from this, there has been a high degree of investments by numerous private and public organizations in the R&D activities to develop advanced technologies in the field of cardiac biomarkers.

Request a Free Sample Research Report:

Market Segmentation:

Breakup by Type

  • Troponins (T and I)
  • Myocardial Muscle Creatine Kinase (CK-MB)
  • Myoglobin
  • Brain Natriuretic Peptide (BNPs) or NT-proBNP
  • Ischemia Modified Albumin (IMA)
  • Others 

Breakup by Location of Testing

  • Laboratory Testing
  • Point of Care Testing

Breakup by Application

  • Myocardial Infarction
  • Congestive Heart Failure
  • Acute Coronary Syndrome
  • Atherosclerosis
  • Others

Breakup by Region

  • North America
  • Asia Pacific
  • Europe
  • Middle East and Africa
  • Latin America 

Competitive Landscape

The competitive landscape of the market has also been examined with some of the key players being Abbott Laboratories, Alere Inc., Beckman Coulter, Becton, Dickinson And Co., Biomerieux, Bio-Rad Laboratories, Randox Laboratories, Roche Diagnostics Corporation, Siemens Healthcare and Thermo Fisher Scientific.

Key highlights of the report:

  • Market Performance
  • Market Outlook
  • Porter’s Five Forces Analysis
  • Market Drivers and Success Factors
  • SWOT Analysis
  • Value Chain
  • Competitive Structure
  • Profiles of Key Players

Browse Full Report with TOC & List of Figure:

Download Global Cardiac Biomarkers Market Research Report PDF Click Here

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact US

Tel No:(D) +91 120 433 0800 |
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331

It’s Press Release News Published by IMARC Group

Sponsor Ads

About Rahul Rastogi Advanced   Market Research Analyst

41 connections, 0 recommendations, 210 honor points.
Joined APSense since, September 6th, 2018, From New York, United States.

Created on Mar 12th 2019 06:00. Viewed 214 times.


No comment, be the first to comment.
Please sign in before you comment.